522 - The Integration of Hepatitis C Treatment into Rural Syringe Services Programs via Telehealth: A Highly Effective Care Model

Saturday, October 19, 2024

12:25 PM – 12:30 PM US PT

Location: Halls JK - Arena 1

Rapid Fire Presenter(s)

Emily Hoff, MD (she/her/hers)

Infectious Disease Fellow
Johns Hopkins
Baltimore, MD, United States

Co-Author(s)

SB

Sherilyn Brinkley, MSN, CRNP

Nurse Practitioner Manager
Johns Hopkins University
Baltimore, Maryland, United States
TA

Tracy Agee, CRNP

Sr. Nurse Practitioner
Johns Hopkins University
Baltimore, Maryland, United States
ML

Maria C. Latimer, MPH

Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
PT

Patricia Tichnell, RN

Johns Hopkins
Baltimore, Maryland, United States
JB

Jackie Bittner, RN

JHU ID Program Manager
Johns Hopkins
Baltimore, Maryland, United States
ES

Elizabeth Spradley, RN, BSN

Maryland Department of Health
Baltimore, Maryland, United States
GB

G. Malik Burnett, M.D.

Maryland Department of Health
Baltimore, Maryland, United States
Mark S. Sulkowski, MD (he/him/his)

Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD, United States
Oluwaseun Falade-Nwulia, MBBS ,MPH (she/her/hers)

Associate Professor
Johns Hopkins University
Baltimore, MD, United States

Disclosure(s):

Sherilyn Brinkley, MSN, CRNP: AbbVie: Honoraria; Gilead Sciences: Honoraria

Tracy Agee, CRNP: No financial relationships to disclose

Jackie Bittner, RN: No financial relationships to disclose

G. Malik Burnett, M.D.: No financial relationships to disclose

Mark S. Sulkowski, MD: AbbVie: Advisor/Consultant (); Aligos Therapeutics: Advisor/Consultant (); Gilead: Advisor/Consultant (); GSK: Advisor/Consultant (), Grant/Research Support (); Janssen: Grant/Research Support (); Precision Biosciences: Advisor/Consultant (); Vir: Grant/Research Support (); Virion: Advisor/Consultant ()

Oluwaseun Falade-Nwulia, MBBS ,MPH: Abbvie Inc: Grant/Research Support (); Gilead Sciences: Advisor/Consultant ()